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Clorobiocin Biosynthesis in Streptomyces:
Identification of the Halogenase
and Generation of Structural Analogs
ocin and its derivatives have also been investigated as
potential anticancer drugs [12–14]. However, due to their
toxicity in eukaryotes, their poor solubility in water, and
their low activity against gram-negative bacteria, clinical
use of these antibiotics remains restricted [2]. Therefore,
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Our group has cloned and sequenced the biosyntheticColney, Norwich NR4 7UH
United Kingdom gene clusters of novobiocin (nov) [18], coumermycin A1
(cou) [19], and clorobiocin (clo) [20]. A uniform nomen-
clature for the genes in these clusters has recently been
introduced [20], replacing the previous names of theSummary
coumermycin biosynthetic genes (see GenBank entry
AF235050 for old and new names).Clorobiocin (clo) and novobiocin (nov) are potent inhib-
The characteristic aminocoumarin moiety is substi-itors of bacterial DNA gyrase. The two substances
tuted at position 8 in novobiocin and coumermycin A1differ in the substitution pattern at C-8 of the amino-
with a methyl group and in clorobiocin with a chlorinecoumarin ring, carrying a chlorine atom or a methyl
atom (Figure 1A). This structural difference is perfectlygroup, respectively. By gene inactivation, clo-hal was
reflected in the organization of the gene clusters: theidentified as the gene of the halogenase responsible
novobiocin and coumermycin A1 clusters contain afor the introduction of the chlorine atom of clorobiocin.
C-methyltransferase gene, i.e., novO and couO, respec-Inactivation of cloZ did not affect clorobiocin forma-
tively [21], whereas the clorobiocin cluster contains thetion, showing that this ORF is not essential for cloro-
gene clo-hal, which shows sequence similarity tobiocin biosynthesis. Expression of the methyltransfer-
FADH2-dependent halogenases [22], at the correspond-ase gene novO in the clo-hal mutant led to the very
ing position (Figure 1B). In addition, the clorobiocin clus-efficient formation of a hybrid antibiotic containing
ter also contains the ORF cloZ, which shows no se-a methyl group instead of a chlorine atom at C-8.
quence similarity to known genes. For all genes of theComparison of the antibacterial activity of clorobiocin
clorobiocin cluster, with the exception of clo-hal andanalogs with -Cl, -H, or -CH3 at C-8 showed that chlo-
cloZ, homologs exist in the novobiocin and/or coumer-rine leads to 8-fold higher activity than hydrogen and
mycin cluster. Since the halogen atom represents theto 2-fold higher activity than a methyl group.
only structural characteristic of clorobiocin absent from
both novobiocin and coumermycin, we were prompted
Introduction to question whether cloZ, together with clo-hal, may
play a role in the halogenation of clorobiocin.
The aminocoumarin antibiotics clorobiocin (also spelled The aims of the present study were, first, to provide
chlorobiocin), novobiocin, and coumermycin A1 (Figure functional proof for the role of clo-hal and cloZ in clorobi-
1A) are potent inhibitors of DNA gyrase produced by ocin biosynthesis by gene inactivation, and, second,
different Streptomyces strains [1–3]. Their characteristic to generate structural analogs of clorobiocin by these
structural moiety is a 3-amino-4,7-dihydroxycoumarin inactivation experiments and by heterologous expres-
unit (Ring B), which is attached to the deoxysugar novi- sion of the putative C-methyltransferase novO.
ose (Ring C). Early investigations of structure-activity
relationships [4, 5] demonstrated that both the amino- Results
coumarin and the substituted deoxysugar moiety are
essential for antibacterial activity. More recent X-ray Sequence Analysis of clo-hal and cloZ
crystallographic examinations [6–8] showed that both The predicted gene product of clo-hal comprises 525
these moieties are involved in binding to the B subunit amino acids and resembles FADH2-dependent halo-
of DNA gyrase. genases, which use phenols or pyrrole derivatives as
Novobiocin (Albamycin, Pharmacia & Upjohn) is li- substrates, such as BhaA of the balhimycin gene cluster
censed in the USA for the treatment of human infections [23, 24], ComH of the complestatin gene cluster [25], and
with gram-positive bacteria such as Staphylococcus PltA of the pyoluteorin gene cluster [26]. The sequence
aureus and S. epidermidis. Its efficacy has been demon- identity of Clo-hal to those three proteins is 36%, 35%,
strated in preclinical and clinical studies [9–11]. Novobi- and 31%, respectively.
The predicted gene product of cloZ comprises 254
amino acids and shows no homology to known proteins.*Correspondence: heide@uni-tuebingen.de
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Figure 1. Aminocoumarin Antibiotics
(A) Structure of the aminocoumarin antibi-
otics.
(B) Map of the clorobiocin biosynthetic gene
cluster of Streptomyces roseochromogenes
var. oscitans DS 12.976 (middle), compared
to the biosynthetic gene clusters of novobio-
cin (top) and coumermycin A1 (bottom).
Inactivation of clo-hal and cloZ in Streptomyces system could therefore be used successfully in S. ro-
seochromogenes var. oscitans, allowing gene inactiva-roseochromogenes var. oscitans DS 12.976
Datsenko and Wanner [27] have recently developed a tion experiments to be carried out much more simply
and quickly than by previous methods [29].rapid method to disrupt chromosomal genes in Esche-
richia coli by replacement with a selectable marker. The
marker is generated by PCR, using primers with 36–50 Characterization of Secondary Metabolites
in the clo-hal and cloZ Mutantsnt extensions that are homologous to the targeted gene.
Recombination of these short homologous sequences Three independent clo-hal mutants (AE-h2, AE-h10,
and AE-h11) and three independent cloZ mutants (AE-with chromosomal DNA is promoted by the  RED func-
tions (gam, bet, exo). This strategy was adapted for use Z4, AE-Z25, and AE-Z40) as well as the wild-type were
cultured in clorobiocin production medium (see Experi-in Streptomyces coelicolor by Gust et al. [28]. We have
used this PCR targeting system to inactivate clo-hal and mental Procedures). After extraction of the cultures with
ethyl acetate, secondary metabolites were analyzed bycloZ in S. roseochromogenes var. oscitans DS 12.976.
Within cosmid D1A8, which contained the biosyn- HPLC in comparison with clorobiocin standard.
The production of clorobiocin was abolished in allthetic gene cluster of clorobiocin in the SuperCos1 vec-
tor (carrying a kanamycin resistance gene), clo-hal was clo-hal mutants (Figure 3B). These mutants produced,
instead, a new substance with a shorter retention timereplaced by an apramycin resistance/oriT cassette (see
Experimental Procedures). The modified cosmid (named than clorobiocin. This compound was isolated on a pre-
parative scale. Negative-ion FAB MS analysis showedD1A8-h-773) was introduced into S. roseochromogenes
var. oscitans by conjugation. Apramycin-resitant, kana- a molecular ion [M-H] at m/z 661, consistent with the
loss of a chlorine atom in comparison to clorobiocinmycin-sensitive colonies, resulting from double cross-
over events, were selected. Southern blot analysis con- ([M-H] at m/z 695). Clorobiocin shows the typical isoto-
pic pattern caused by the chlorine isotopes 35Cl andfirmed that in these mutants clo-hal was replaced by the
apramycin resistance/oriT cassette (Figures 2A and 2B). 37Cl (mass [intensity]: 695 [100.0%], 696 [32.6%], 697
[31.8%], 698 [11.1%]), whereas the negative-ion FABcloZ was inactivated in the same way, and the correct
genotype of the resulting double crossover mutants was MS of the new substance did not show this pattern,
indicating the absence of chlorine (mass [intensity]: 661confirmed by Southern blot analysis (Figures 2C and 2D).
With some modifications of the conjugation proce- [100.0%], 662 [25.9%], 663 [9.5%]). 1H NMR (Table 1)
and 13C NMR (Table 2) unequivocally confirmed that thedure (see Experimental Procedures), the PCR targeting
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Figure 2. Inactivation of clo-hal and cloZ in S. roseochromogenes
(A) Schematic presentation of the clo-hal inactivation experiment. The DNA fragment used as probe is indicated as a black bar. aac(3)IV,
apramycin resistance gene; Paac, promoter of the apramycin resistance gene; FRT, FLP recognition target; oriT, origin of transfer from RK2;
neo, kanamycin resistance gene. Out of scale.
(B) Southern blot analysis of wild-type and clo-hal mutants. Genomic DNA was restricted by Eco0109I. Abbreviations: M, DIG-labeled DNA
Molecular Weight Marker VII (Roche); WT, S. roseochromogenes var. oscitans wild-type; 1–3: clo-hal mutants (strains AE h2, AE h10, and
AE h11).
(C) Schematic presentation of the cloZ inactivation experiment. The DNA fragment used as probe is indicated as a black bar. Out of scale.
(D) Southern blot analysis of wild-type and cloZ mutants. Genomic DNA was restricted by BamH1. Abbreviations: M, DIG-labeled DNA
Molecular Weight Marker VII (Roche); WT, S. roseochromogenes var. oscitans wild-type; 1–3, cloZ mutants (strains AE-Z4, AE-Z25, and
AE-Z40).
new substance was a clorobiocin derivative containing reported from a naturally occurring novobiocin deriva-
tive lacking the 8-methyl group [30]. In the 13C NMRa hydrogen instead of a chlorine atom at C-8 of Ring
B. In the 1H NMR spectrum of the new compound, the spectrum, the signal corresponding to C-8 was found
at 104.0 ppm (instead of 110.7 ppm as for clorobiocin),signal at 7.33 ppm corresponding to H-6 of clorobiocin
had disappeared. Instead, a signal at 7.06 ppm for two and the signal corresponding to C-6 was at 115.0 ppm
(clorobiocin, 112.5 ppm). This is also in accordance withprotons was observed as a broad singlet, which could be
assigned to H-6 and H-8 by correlated spectroscopy literature data [30].
The new compound was named novclobiocin 101.(COSY). The coincidence of the signals of H-6 and H-8
as a broad singlet is in accordance with the spectrum The clo-hal mutants produced 35–45 g novclobiocin
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under the present culture conditions, and apparently is
not involved in the halogenation reaction.
Complementation of the clo-hal Mutation
To prove that only the inactivation of clo-hal was respon-
sible for the loss of the chlorine atom, we complemented
the clo-hal mutant by expression of an intact copy
of clo-hal under the control of the constitutive ermE*
promoter, using the expression vector pUWL201 (plas-
mid pAE-ha7). HPLC analysis showed a chromatogram
identical to that of the wild-type, i.e., clorobiocin produc-
tion could be fully restored by expression of clo-hal.
The authenticity of the obtained peak was confirmed
by negative-ion FAB MS analysis (mass [intensity]: 695
[100.0%], 696 [36.5%], 697 [30.2%], 698 [10.5%]).
Combinatorial Biosynthesis: Expression of novO
in the clo-hal Mutant
novO encodes a putative methyltransferase [18]. A very
similar gene, couO, in the coumermycin A1 biosynthetic
cluster [19] (Figure 1B) has been experimentally con-
firmed to determine the methylation of C-8of the amino-
coumarin ring [21]. NovO shows 84% identity to CouO,
and both proteins are of equal size (230 aa). The con-
served motif III [LL(R/K)PGG(R/I/L)(L/I)(L/F/I/V)(I/L)] for
S-adenosyl-methionine-dependent methyltransferases
[31] is found in both gene products from amino acid 135
to 144 (CouO, LVKPGGAILN; NovO, LAKPGGAVLN).
In order to produce a hybrid antibiotic, the putative
methyltransferase gene novO was expressed in the clo-
hal mutant. For this purpose, novO was cloned into
the replicative expression vector pUWL201 (see Experi-
mental Procedures), placing it under the control of the
constitutive ermE* promoter. The resulting construct,
pTLO5, was introduced into the clo-hal mutant by pro-
toplast transformation. As control, the clo-hal mutant
was transformed with the empty vector pUWL201.
Culture extracts of the two strains were analyzed by
HPLC. In each case, three independent transformants
were examined. While transformants containing the
empty vector still produced novclobiocin 101 (data not
shown), transformants containing the novO construct
Figure 3. HPLC Analysis of Secondary Metabolites showed instead a new compound (Figure 3D) with a
(A) S. roseochromogenes var. oscitans wild-type. longer retention time than novclobiocin 101. Negative-
(B) clo-hal mutant.
ion FAB MS analysis of the isolated substance showed(C) cloZ mutant.
a molecular ion [M-H] at m/z 675, corresponding to the(D) clo-hal mutant transformed with the novO expression construct
addition of a methyl group to the molecule of novclobio-(pTLO5).
cin 101. 1H NMR (Table 1) and 13C NMR (Table 2) analysis
unequivocally confirmed that this substance was a clor-
obiocin derivative in which the chlorine atom at C-8 of101 per milliliter medium, which exceeded the clorobio-
cin production of the wild-type (25 g/ml). the aminocoumarin ring is replaced with a methyl group.
In comparison to the 1H NMR spectrum of clorobiocinIn contrast to the clo-hal mutants, all cloZ mutants
produced clorobiocin (Figure 3C). The production level (Table 1), an additional singlet at 2.34 ppm correspond-
ing to three protons was detected, which could be as-was similar to that of the wild-type strain (25 g/ml).
The identity of the clorobiocin produced by the cloZ signed to 8-CH3, based on literature data [30]. In com-
parison to novclobiocin 101, the signal of H-8 hadmutants was confirmed by negative-ion FAB MS (molec-
ular ion [M-H] at m/z 695) and 1H NMR analysis (the disappeared, and the signal of H-6 was found as dou-
blet at 7.24 ppm, as reported in the literature [30]. In thespectrum obtained was identical to that of authentic
clorobiocin; Table 1). 13C NMR spectrum (Table 2), a new signal at 8.7 ppm
was observed, which could be assigned to C-11, usingAlthough the presence of cloZ within the clorobiocin
cluster is suggestive of a function related to the forma- 1H, 13C correlated spectroscopy (COSY). This was also
in accordance with the literature [30].tion of this antibiotic, the above experiments show that
cloZ is clearly not essential for clorobiocin biosynthesis The new compound was named novclobiocin 102. It
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Table 1. 1H NMR Data of Clorobiocin, Novclobiocin 101, and Novclobiocin 102 in d4-Methanol
Compound
Clorobiocin Novclobiocin 101 Novclobiocin 102
Position , Multiplicity (J/Hz) , Multiplicity (J/Hz) , Multiplicity (J/Hz)
2-H 7.76 d (2.5) 7.77 d (2.1) 7.76 br s
5-H 6.84 d (8.4) 6.84 d (8.4) 6.84 d (8.3)
6-H 7.72 dd (8.4; 2.5) 7.72 br d (8.0) 7.72 br d (8.5)
7-H2 3.34 d (7.1) 3.34 d (7.0) 3.34 d (7.2)
8-H 5.35 bra t (7.1) 5.35 br t (7.3) 5.35 br t (7.2)
10-H3 1.74 s 1.74 s 1.74 s
11-H3 1.75 s 1.75 s 1.75 s
5-H 7.90 d (9.2) 7.92 d (9.4) 7.82 d (8.8)
6-H 7.33 d (9.2) 7.06b 7.24 d (8.7)
8-H - 7.06b -
11-H3 - - 2.34 s
1″-H 5.73 d (1.8) 5.63 d (2.0) 5.63 d (1.6)
2″-H 4.34 t (2.7) 4.24 t (2.6) 4.29 br s
3″-H 5.71 dd (10.3; 2.9) 5.59 dd (9.8; 3.2) 5.67 dd (9.9; 3.1)
4″-H 3.72 d (10.3) 3.70 d (9.8) 3.71 d (9.9)
6″-H3 1.18 s 1.20 s 1.18 s
7″-H3 1.35 s 1.37 s 1.36 s
8″-OCH3 3.52 s 3.51 s 3.52 s
3-H 6.90 d (3.6) 6.90 d (3.6) 6.90 d (3.6)
4-H 5.94 br d (3.6) 5.94 d (3.6) 5.94 br d (3.4)
6-H3 2.29 s 2.29 s 2.29 s
 is given in ppm. The solvent signal (3.30 ppm) was used as reference. Spectra were obtained at 400 MHz (clorobiocin and novclobiocin
102) or at 600 MHz (novclobiocin 101).
a br indicates broad signal.
b Complex, overlapping signals; J not determinable.
was produced in an amount of 28–58 g per ml medium Clorobiocin showed the highest antibacterial activity,
followed by novclobiocin 102 (approximately half as ac-(data of three independent transformants), exceeding
the amount of clorobiocin produced in the wild-type (25 tive as clorobiocin) and novclobiocin 101 (approximately
eight times less active than clorobiocin). The resultsg/ml).
In the wild-type and in all mutant strains, an additional show that a substitution at C-8 of Ring B strongly en-
hances the activity of the aminocoumarin antibioticspeak with a slightly longer retention time than the re-
spective main product was observed (Figures 3A–3D). against this test organism. A chlorine atom at this posi-
tion appears to be superior to a methyl group, althoughNegative-ion FAB MS analysis of these minor peaks
showed the same molecular ion as the corresponding the difference is moderate.
main product. These compounds are likely to represent
isomers of the main products, possibly carrying the pyr- Discussion
role carboxylic acid moiety in position 2 instead of posi-
tion 3 of the deoxysugar [20]. The present work provides experimental proof for the
function of clo-hal of the clorobiocin gene cluster and
of novO of the novobiocin gene cluster, and shows thatAntibacterial Activity of Novclobiocin 101 and
Novclobiocin 102 in Comparison to Clorobiocin cloZ is inessential for clorobiocin biosynthesis. More-
over, two clorobiocin analogs with different substitu-Authentic clorobiocin (Aventis), novclobiocin 101 (from
the clo-hal mutant), and novclobiocin 102 (from the tions at C-8 of the aminocoumarin ring were produced
by genetic manipulation.clo-hal mutant transformed with novO) were assayed
for antibiotic activity against Bacillus subtilis (Figure 4). The clo-hal gene product is responsible for the intro-
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Table 2. 13C NMR Data of Clorobiocin, Novclobiocin 101, and Novclobiocin 102 in d4-Methanol at 100 MHz
Compound
Clorobiocin Novclobiocin 101 Novclobiocin 102
Position  (ppm)  (ppm)  (ppm)
1 124.2 124.3 124.3
2 130.9 130.8 130.8
3 129.9 129.8 129.8
4 161.0 160.9 160.9
5 115.6 115.6 115.6
6 128.5 128.5 128.4
7 29.2 29.2 29.2
8 123.2 123.2 123.2
9 133.8 133.8 133.8
10 17.9 17.9 17.9
11 26.0 26.0 26.0
12 170.0 169.8 169.7
2 162.4a 163.3a 163.5a
3 103.7 103.4 103.3
4 157.8a 158.7a 158.8a
5 123.9 126.4 123.2
6 112.5 115.0 111.7
7 161.8a 161.3a 158.8a
8 110.7 104.0 114.9
9 156.5 154.1 151.7
10 113.3 112.4 112.4
11 - - 8.7
1″ 100.4 100.1 100.0
2″ 71.0 70.9 71.0
3″ 71.6 71.6 71.8
4″ 82.7 82.7 82.7
5″ 80.5 80.15 80.1
6″ 22.9 23.4 23.2
7″ 29.3 29.0 29.2
8″ 62.1 62.0 62.0
2 121.8 121.8 121.8
3 118.33 118.4 118.4
4 109.8 109.8 109.8
5 136.3 136.4 136.3
6 12.9 12.9 12.9
7 161.8a 161.9a 161.9a
The signal of the solvent (49.0 ppm) was used as reference. Assignments were made with the help of 1H, 13C COSY, and the literature [30, 40].
a Signal of carbon 2, 4, 7, and 7 showed similar chemical shift (157.8–163.5 ppm), and their assignment may be interchanged.
duction of the halogen atom of clorobiocin. The mecha- diate [22]. In vitro, these enzymes require the presence
of an unspecific flavin reductase generating FADH2. Thisnism of halogenation reactions, which are involved in
the biosynthesis of at least 3000 natural halometabolites reductase appears not to be encoded within the gene
clusters of the above mentioned secondary metabolites,[32], is not yet completely understood. Clo-hal shows
sequence similarity to the recently discovered class of similar to our finding for the clorobiocin cluster. Our
functional identification of clo-hal reinforces the impor-FADH2-dependent halogenases [22], such as are in-
volved in the biosynthesis of chlortetracycline [33], the tance of this new class of halogenases for natural prod-
uct biosynthesis.glycopeptide antibiotic balhimycin [24], and pyoluteorin
[26]. It has been speculated that the reactions catalyzed Expression of novO from the novobiocin cluster in the
clo-hal mutant led to the very efficient formation of anby these enzymes may proceed via an epoxide interme-
Figure 4. Antibacterial Activity of Clorobiocin
and Derivatives
(A) clorobiocin, (B) novclobiocin 101, and (C)
novclobiocin 102.
Bioassay with Bacillus subtilis. 0, methanol;
1–5, 0.5 g, 1 g, 2 g, 4 g, and 8 g of
the respective substance. For structures see
Table 1.
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Figure 5. Hypothetical Biosynthetic Pathway of Clorobiocin
It is not clear at which exact step during the biosynthesis halogenation takes place (see Discussion).
8-methylated compound, i.e., novclobiocin 102. To- and Walsh [34] provided evidence that the methylation
occurs after activation of tyrosine, which is the first stepgether with the previously published inactivation of the
very similar gene couO from the coumermycin cluster in aminocoumarin formation (Figure 5), and an inactiva-
tion experiment by Steffensky et al. [18] demonstrated[21], this result provides conclusive evidence that NovO
and CouO catalyze the C-methylation reaction in the that methylation takes place before glycosylation of no-
vobiocic acid. In Figure 5, we tentatively suggest thebiosynthesis of the aminocoumarin rings of novobiocin
and coumermycin. activated form of -hydroxy-tyrosine as the substrate
for the halogenation. In any case, for the assembly ofIt is not clear at present at which step of aminocouma-
rin biosynthesis the methylation or halogenation reac- the entire novobiocin or clorobiocin molecule, several
enzymatic steps are required to take place after thetions takes place. For novobiocin biosynthesis, Chen
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methylation or halogenation, respectively (Figure 5). It Bioassays showed that the chlorine atom of cloro-
biocin is important for biological activity, resulting inis remarkable that the yields of novclobiocin 101 (8-H),
produced by the clo-hal mutant, and 102 (8-CH3), pro- higher antibacterial activity than a methyl group in the
same position.duced by the clo-hal mutant expressing novO, were at
least as high as that of clorobiocin (8-Cl) in the wild-
Experimental Procedurestype. This indicates a low specificity of the subsequent
biosynthetic enzymes for the substituent at the 8 posi-
Bacterial Strains, Plasmids, and Culture Conditionstion, a very useful feature for the development of new
E. coli-Streptomyces shuttle vector pUWL201 was kindly provided
aminocoumarin antibiotics by combinatorial approaches. by A. Bechthold (Freiburg, Germany) and was originally obtained
In the present study, this allowed the production of the from W. Piepersberg (Wuppertal, Germany). Cosmid D1A8 con-
two clorobiocin analogs mentioned above, and a first tained the clorobiocin biosynthetic gene cluster [20] in the Su-
perCos1 vector. Cosmid 9-6G, used for construction of pTLO5, wascomparison of these compounds with clorobiocin re-
described previously [18].garding their antibacterial activity.
Streptomyces roseochromogenes var. oscitans DS 12.976 wasStructurally, clorobiocin differs from novobiocin in the
kindly provided by Aventis and routinely cultured in baffled Erlen-
substitution at C-8 of the aminocoumarin ring and at meyer flasks containing a stainless steel spring. YMG medium liquid
the C-3″of the deoxysugar moiety (Figure 1). Clorobiocin or solid (2% agar) containing 1% malt extract, 0.4% yeast extract,
has been reported to show a six times higher antibacte- 0.4% glucose (pH 7.3) was used routinely for cultivation, carried out
at 30C and 180 rpm for 2 to 3 days. For preparation of genomicrial activity than novobiocin in vitro [4] and to bind more
DNA, wild-type and mutant strains of S. roseochromogenes wereefficiently to isolated gyrase [6–8]. Most authors have
grown in YEME medium without glycine [29]. For preparation ofattributed the higher activity of clorobiocin primarily to
protoplasts, CRM medium [20] was used. For conjugation, cells
the pyrrole moiety at C-3″ [7, 35]. Interestingly, however, were cultured in a 1:1 mixture of TSB and YEME medium [29] without
clorobiocic acid (Figure 5), but not novobiocic acid, was glycine for 2 to 3 days at 30C and 180 rpm. 2YT broth, containing
found to inhibit both DNA synthesis in vivo and gyrase 1.6% tryptone, 1% yeast extract, and 0.5% NaCl (pH 7.0), was used
during conjugation (see below). For analysis of secondary metabo-activity in vitro [5, 36], suggesting that the chlorine atom
lites, cells were precultured in 50 ml cornstarch medium (1% corn-makes an important contribution to the biological activ-
starch, 1% peptone, 0.5% meat extract [pH 7.0]) for 2 days at 33City of this molecule. The clorobiocin analogs produced
and 210 rpm. Five milliliters of this preculture was inoculated into
in the present study allowed a comparison of aminocou- 50 ml of production medium adapted from [37], prepared from 4.8%
marin compounds, which differ only in the substitution distillers’ solubles, 3.7% glucose, 0.0024% cobalt chloride (at this
at C-8, i.e., carrying a chlorine, a methyl group or a point, the pH of the mixture was adjusted to 7.8), 0.6% calcium
carbonate, and 0.2% ammonium sulfate. Cultivation was carried outhydrogen atom at that position. In a bioassay with Bacil-
in 500 ml baffled flasks for 5 to 8 days at 33C and 210 rpm.lus subtilis (Figure 4), clorobiocin (8-Cl) was twice as
Escherichia coli XL1 Blue MRF (Stratagene, Heidelberg, Ger-active as novclobiocin 102 (8-CH3) and eight times more many) was used for cloning experiments and grown in liquid or on
active than novclobiocin 101 (8-H). solid Luria-Bertani medium (1.5% agar) at 37C [38]. Before trans-
formation of S. roseochromogenes, the recombinant plasmids
Significance were amplified in E. coli ET12567 to bypass methyl-sensing restric-
tion [39].
The REDIRECT technology kit containing E. coli ET12567, E.Clorobiocin (clo) and novobiocin (nov) are potent inhib-
coli ET12567/pUZ8002, E. coli BW25113/pIJ790, and E. coli DH5	/itors of bacterial DNA gyrase. Their characteristic
pIJ773 [28] was obtained from Plant Bioscience Limited (Norwich
aminocoumarin moiety is substituted at C-8 with a Research Park, Colney, Norwich).
chlorine atom in clorobiocin and with a methyl group Thiostrepton (50 g/ml for solid media and 40 g/ml for liquid
in novobiocin. media), apramycin (50 g/ml), kanamycin (50 g/ml), chlorampheni-
col (25–50 g/ml), nalidixic acid (25 g/ml), and carbenicillin (50–100The results presented here demonstrate that the
g/ml) were used for selection of recombinant strains.gene clo-hal is responsible for halogenation of posi-
tion 8 of the aminocoumarin ring of clorobiocin, while
DNA Isolation, Manipulation, and CloningnovO is responsible for methylation of the correspond-
Standard procedures for DNA isolation and manipulation were per-ing position of novobiocin. cloZ is not involved in the formed as described by Sambrook et al. [38] and Kieser et al. [29].
halogenation, nor is it essential for clorobiocin biosyn- Isolation of DNA fragments from agarose gel and purification of PCR
thesis under the present culture conditions. The func- products were carried out with the NucleoSpin 2 in 1 Extract Kit
(Macherey-Nagel, Du¨ren, Germany). Isolation of cosmids and plas-tional identification of antibiotic biosynthetic genes
mids was carried out with ion-exchange columns (Nucleobond AXprovides important information for the generation of
kits, Macherey-Nagel, Du¨ren, Germany) according to the manufac-structurally modified compounds by combinatorial
turer’s protocol. Genomic DNA was isolated from S. roseochromo-biosynthesis. An example of this approach is given by
genes strains using the Kirby mix procedure [29].
heterologous gene expression of the methyltransfer- Southern blot analysis was performed on Hybond-N nylon mem-
ase novO in a clo-hal mutant, which led to production brane (Amersham, Braunschweig, Germany) with digoxigenin-
of a hybrid antibiotic in excellent yield. Similar inactiva- labeled probe by using the DIG high prime DNA labeling and detec-
tion starter kit II (Roche Molecular Biochemicals).tion/expression experiments, possibly combined with
feeding of synthetic precursors, are expected to pro-
Inactivation of clo-hal in S. roseochromogenesduce a range of new aminocoumarin antibiotics, possi-
clo-hal was inactivated using the PCR targeting system [28], whichbly with improved properties. The PCR targeting sys-
takes advantage of the  RED recombination functions (gam, bet,tem proved to be a fast and effective method for gene
exo) to promote gene replacement. An aac(3)IV (apramycin resis-
inactivation in Streptomyces roseochromogenes var. tance gene)/oriT cassette for replacement of clo-hal was generated
oscitans and opens improved possibilities for genetic by PCR using the primer pair P1-clo-hal (5-ATTGGCGATTTATCGTC
AGCGGTTGGAGGAAGTAGCGTGATTCCGGGGATCCGTCGACC-3)engineering.
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and P2-clo-hal (5-AGCCTTCGGGCGAGAAGTCCTCGTCACGTAC of ethylacetate. After evaporation of the solvent, the residue was
redissolved in 0.5 ml ethanol. After centrifugation, 10 to 100 l ofCGCGCTTATGTAGGCTGGAGCTGCTTC-3). Underlined letters rep-
resent 39 nt homologous extensions to the DNA regions immediately the clear supernatant was analyzed by HPLC with a Multosphere
RP18-5 column (250  4 mm; 5 m; C
S Chromatographie Service,upstream and downstream of clo-hal, respectively, including the
putative start and stop codons of clo-hal. This cassette was intro- Du¨ren, Germany) at flow rate of 1 ml/min, using a linear gradient from
40% to 100% of solvent B in 25 min (solvent A, MeOH:H2O:HCOOH,duced into E. coli BW25113/pIJ790, containing cosmid D1A8 (Su-
perCos1-based, kanamycin-resistant), which included the entire 50:49:1; solvent B, MeOH:HCOOH 99:1), with detection at 340 nm.
Authentic clorobiocin (Aventis) was used as standard.biosynthetic gene cluster of clorobiocin. The gene replacement was
confirmed by restriction analysis and PCR using test primers TP1- For preparative isolation, an extract of 500 ml bacterial culture
was prepared and purified by HPLC as described above. The prod-clo-hal (5-GGAACGGAAGCTTGGCTATC-3) and TP2-clo-hal (5-
GAAGTGCGACAGGATCTGGA-3). uct was analyzed by 1H NMR and 13C NMR spectroscopy and by
negative-ion FAB mass spectrometry. Negative-ion FAB mass spec-The mutated cosmid (termed D1A8-h-773) was introduced into
Streptomyces roseochromogenes by conjugation from E. coli tra were recorded on a TSQ70 spectometer (Finnigan, Bremen, Ger-
many) using diethanolamine as matrix.ET12567 carrying the nontransmissible pUZ8002. The conjugation
procedure was adapted from Gust et al. [28] and Kieser et al. [29]. 1H NMR and 13C NMR spectra were measured either on an AMX
400 or on an AMX600 spectrometer (Bruker, Karlsruhe, Germany),Fresh mycelium from 50 ml TSB/YEME 1:1 liquid culture was used
instead of spores. After centrifugation, the mycelium was washed using CD3OD as solvent.
with 10.3% sucrose solution and resuspended in 5 ml 2YT broth.
Five hundred microliters of the Streptomyces suspension was gently Bioassay
mixed with 500 l of the E. coli suspension (treated as described Antibacterial activity of authentic clorobiocin (Aventis), novclobiocin
in [29]). The mixture was spread on two MS plates [29] and incubated 101, and novclobiocin 102 was tested using Bacillus subtilis ATCC
at 30C for about 18 hr, then overlaid with 1 ml water containing 14893. For the bioassays, 0.5, 1, 2, 4, and 8 g of the respective
1.25 mg apramycin and 0.5 mg nalidixic acid. Incubation at 30C was substance in 10 to 20 l methanol were applied to filter paper disks
continued for about a week to allow outgrowth of the exconjugants. (6 mm diameter) and dried in the air for 30 min. The filter disks were
Apramycin-resistant, kanamycin-sensitive colonies were identified then placed on Difco nutrient agar plates [29] containing approxi-
by replica plating and characterized by PCR (using the test primers mately 2  105 spores of Bacillus subtilis per milliliter agar medium.
mentioned above) and Southern blot analysis. After culturing overnight at 37C, the diameter of the growth inhibi-
tion zone was determined.
Inactivation of cloZ in S. roseochromogenes
cloZ was inactivated as described for clo-hal. The primer pair used Computer-Assisted Sequence Analysis
for amplification of the aac(3)IV/oriT cassette was P1-cloZ (5-GGC The DNASIS software package (version 2.1; Hitachi Software Engi-
CTGTCAGGCGTTAACGGCGTTGACTCGTCGATGATGATTCCGGG neering, San Bruno, CA) and the BLAST program (release 2.2.3)
GATCCGTCGACC-3) and P2-cloZ (5-CCGGCGTAACCCTCCG CGG were used for sequence analysis and for homology searches in the
TCGCCAGTCGCGCTGCGTCATGTAGGCTGGAGCTGCTTC-3). GenBank database, respectively.
Test primers were TP1-cloZ (5-GATCCTGAATTGGCCATCAAC-
3) and TP2-cloZ (5-ATGCGTCAGACGAGAACTCAC-3). Acknowledgments
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